In humans, a decline in IGF-I levels has been shown to be associated with a significantly higher incidence of diabetes, osteoporosis, dementia, and Alzheimer’s disease [51,52,53]. The gene discussed is IGF1; the disease is early-onset autosomal dominant Alzheimer disease.